PlainRecalls

AstraZeneca LP

Compiled from official public sources by the publisher.

3 recalls on record · Latest: Mar 20, 2013

Subscribe to new AstraZeneca LP recalls (RSS)

Agency notice ledger

Federal filing book AstraZeneca LP LIGHT-BOOK · SINGLE-AGENCY

#3,359 of 14,151 · 3 notices · 0.003% archive

  • BOOK 3 notices
  • RANK #3,359 of 14,151
  • SHARE 0.003% archive
  • AGENCY FDA Drug (3)
  • CAT drugs
  • CATS 2 categories
  • LATEST Mar 20, 2013
  • PHOTO 3B Medical, Inc.

Nearest notice-volume peer: 3B Medical, Inc. (0 notice gap)

AstraZeneca LP accounts for about 0.003% of the 104,423-notice archive on 3 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

Where AstraZeneca LP sits among 14,151 recalling firms

AstraZeneca LP ranks 3,359th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

AstraZeneca LP vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

3 3359th of 14151 higher than 9,908 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-17

AstraZeneca LP in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows AstraZeneca LP holds about 0.003% of archive notices alongside 3 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Mar 20, 2013

PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04
FDA Drug Low Mar 20, 2013

PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/carton) NDC: 0186-1988-04
FDA Drug Low Jul 18, 2012

Nexium (esomeprazole magnesium) Delayed-Release Capsules, 40 mg, 1000-count bottle, Rx only, Manufactured for: AstraZeneca LP, Wilmington, DE 19850; By: AstraZeneca AB, S-151 85 Sodertalje, Sweden, NDC 0186-5040-85, UPC 3 0186-5040-85 0.

AstraZeneca LP is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar recall count

Nearest multi-notice firms by distinct-event totals (3 here).

3B Medical, Inc. 3 7-Eleven, Inc. 3 A & C Best Food Trading 3 A B Nutrition, Inc. 3 A L I Technologies Ltd 3

Similar drugs volume

Nearest multi-notice firms that share this firm's dominant product category.

A B Nutrition, Inc. 3 Abrams Royal Pharmacy 3 Actavis 3 Ajanta Pharma Ltd. 3

Frequently Asked Questions

How many federal recall notices name AstraZeneca LP? ▼
PlainRecalls indexes 3 distinct federal recall events naming AstraZeneca LP, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does AstraZeneca LP sit among other recalling firms? ▼
AstraZeneca LP ranks #3,359 of 14,151 by distinct recall-event count among 14,151 firms in this archive (70th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of AstraZeneca LP's notices? ▼
FDA Drug accounts for 3 of this firm's 3 indexed notices.
What product category dominates AstraZeneca LP's filing book? ▼
Filings for AstraZeneca LP span 2 product categories, led by drugs. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
AstraZeneca LP: 3 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming AstraZeneca LP; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026